EVOkit Launching


EvoEnzyme is proudly announcing the release of the EVOkit: the first 
screening kit in the market carrying a selected collection of 
laboratory evolved peroxygenases -UPOs- from different fungal species. 
With a broad activity and selectivity profile, the rapid 
oxyfunctionalization of complex organic compounds comes true for pharma and chemical processes. (More info)










We were at the III Spanish Days of Biocatalysis 2021


This week our evolvers were at the IIISPANISH DAYS OF BIOCATALYSIS,  Ivan Mateljak y Javier Viña were talking about our peroxygenase mutants applied for the Pharma & Environmental sector. Besides, our most recent advances in the BBI- BIZENTE PROJECT for thermoset composites biodegradation.






Our CEO, selected to be part of the 1st Guide of Women referents of Innovative Entrepreneurship in Spain. 


Developed by the Alto Comisionado para España Nación Emprendedora and WStartupC. (More info)







Our CEO, María Urbano, was invited to speak about the challenges and needs of entrepreneurs together with other entrepreneurs and personalities from the Comunity of Madrid, Fundación para el Conocimiento Madri+d, CSIC, CIEMAT, UAM & UCM. (More info)




Webinar Bizente Project Mayo 5 2021



EvoEnzyme achieves, together with its partners (REPSOL, IMDEA Energi, ARIEMA Energia y Medioambiente y SEENSO Renoval), one of the two grants awarded by the Community of Madrid in its HUB INNOVACION call.


Our CTO, invited to talk about  innovation 


On the occasion of the visit of the Vice President for Universities, Science and Innovation of the Community of Madrid to the Parque Científico, EvoEnzyme has been selected to present its project as an example of a young company with high technological intensity that is a benchmark in the park. Our CTO, Bernardo Gómez, attended this great event.


Interview to Xavi Viña 


Our Science Manager Xavier Viña was  interviewed to talk about BIZENTE Project.” “BIZENTE applies a revolutionary system on composites”. (More info)




EvoEnzyme funded by Torres Quevedo Program


EvoEnzyme has achieved a second grant from theTorres Quevedo program, funded by the Ministry of Science, allowing the company to incorporate a new PhD to its staff!




 in BIOTRANS 2021



We are proud to introduce our first Peroxygenase based KIT (EVO -KIT) for the pharma and chemical sectors in the BIOTRANS Conference.




Webinar Bizente Project Mayo 5 2021


 with the FECYT 


Our Founder, Miguel Alcalde was interviewed by Fundación Española para la Ciencia y la Tecnología, FECYT. A very interesting event aimed at beneficiaries and managers of Era-CoBiotech projects where Miguel spoke about “Entrepreneurial culture from research”. 



Open Expo 21 Maria Urbano


 in OpenExpo21


Maria Urbano, EvoEnzyme´s CEO, will participate in this great event where she will talk about Entrepreneurship & Sustainability. Don’t miss it!


Webinar Bizente Project Mayo 5 2021


 in the European Green Week


Javier Viña, our Science Manager, shows, in this interesting webinar, how designing enzymes for plastic degradation and valorization. 






Miguel Alcalde, Founder of EvoEnzyme, participates in EXPOQUIMIA BIO talking about “Green Deal: the path to a climate neutral Europe“. Join us!




 granted with NEOTEC 


EvoEnzyme selected by the CDTI – Centro para el Desarrollo Tecnológico Industrial as beneficiaries of this prestigious grant program, NEOTEC.


 talking about Entrepreneurship


Join us and know the new study of the Fundación para el Conocimiento madri+d , “Startup Radar madri + d”.

Our CEO, Maria Urbano, will tell us about EvoEnzyme’s experience undertaking . (More info)



 Gold Sponsor of the Biocatalysis Open Day 20


Don’t miss our introducing video and our work on evolution of resurrected laccases. (More info)



Repsol Foundation presents the six new startups of its business acceleration program



Know more in …  (More info)


Miguel Alcalde in SusChem


Miguel Alcalde, Founder of EvoEnzyme, will participate in the round table on Chemistry and Sustainability during the next SusChem General assembly. 


EvoEnzyme, Finalist Innovatia Prize!!!


EvoEnzyme is one of the three finalists selected by the Innovatia 8.3 program.  (More info).

EvoEnzyme, Innovative SME


EvoEnzyme got the the Innovative SME seal!!!!


EvoEnzyme at IV Inspiring Women Leaders in the Digital Era


Our CEO, María Urbano was invited to talk about entrepreneurship in this great event-. (More info)

Learn more about EU BBI Bizente Project 


Bizente Project has started. Visit our website and YouTube channel and know more about it!. (More info).

The newspaper La Razón interviews us 


The section “Innovadores” of La Razón interviews EvoEnzyme founders. (more info).

EvoEnzyme funded by Torres Quevedo Program


EvoEnzyme has achieved a grant from theTorres Quevedo program, funded by the Ministry of Science, allowing the company to incorporate a new PhD to its staff!

EvoEnzyme selected for acceleration!


EvoEnzyme has been selected to join the 9th Entrepreneurs Fund Startup Accelerator Program focused on technological projects for energy transition. Our company was selected among 1,275 candidates from 83 different countries. (more info).

BBI-H2020 BIZENTE Project


EvoEnzyme is participating as a full partner in the 4-year project BIZENTE (H2020-BBI-JTI-2019) aimed at degrading thermoset composites.

Madri+d interviews our CEO


Maria Urbano, CEO of EvoEnzyme, has been interviewed by Madri+d. (More info).

EvoEnzyme joins Susplast


EvoEnzyme joins the CSIC Susplast (Interdisciplinary Platform for Sustainable Plastics towards a Circular Economy) to implement plastics management within a circular economy:

EVOFARMA Project: the CAM-RIS 3 grant


EvoFarma, the innovative EvoEnzyme´s project, has been granted with a CAM-RIS 3 for young innovative companies from the Community of Madrid and the European Regional development.

 Invited lecture at IQAC

04/03/2020, Barcelona, Spain.

Miguel Alcalde, EvoEnzyme Founder & Advisor, gave an invited lecture in the seminar program of IQAC.

EvoEnzyme at the III Simposio de la Unidad de Excelencia Química Aplicada, Biomedicina y Medioambiente

17/01/ 2020, University of Granada, Spain.

Miguel Alcalde, EvoEnzyme Founder & Advisor, made an invited lecture introducing the Company.

EvoEnzyme 1st PATENT


EvoEnzyme signs an exclusive license agreement with CSIC for the exploitation of evolved peroxygenases (WO/2017/081355 approved in Europe and United States).

EvoEnzyme in COP25

2/12/2019 Madrid

The CSIC presents at COP25 six technology-based companies to face the challenges of climate change, and EvoEnzyme was one of them!!! (More info).

EvoEnzyme at TrEnCa 2019

29/11/ 2020, Benicassim, Spain.

Miguel Alcalde, EvoEnzyme Founder & Advisor, made an invited lecture introducing the Company.

EvoEnzyme, “Revelation Startup Award 2019”

During “III Inspiring Women Leaders in the digital Era” event in Repsol in Madrid, Women StartupCommunity awarded to EvoEnzyme as the Revelation Startup of 2019.
For further information, please visit

EvoEnzyme collaboration


EvoEnzyme as collaborator of SynCell participated on SynCell2019.

An event in which scientists from all over the world were discussing the different applications of artificial cells in health, food, renewable energy and biomaterials. More info in:

EvoEnzyme in #WER19


The Women in Entrepeneurship European Roadshow 2019 organized by the European Young Innovators Forum selected Maria Urbano, our CEO and Co-Founder to join this event. She was one of the 300 women, 30 VCs, 10 cities in 1 year. (More info).

EvoEnzyme, The most innovative technological initiative in Health


Last December 2018, EvoEnzyme was awarded with the first prize of Madrid Health Start from Madri+D Foundation, which promotes the launch of the most promising start-ups biotech companies in the field of health in Spain. (More info).